Searchable abstracts of presentations at key conferences in endocrinology

ea0032oc1.1 | Pituitary & Molecular Endocrinology | ECE2013

The consequences of changing endogenous GH/IGF1 levels on carcinogen-induced mammary gland tumorigenesis are dependent on metabolic status in mice

Gahete Manuel D , Cordoba-Chacon Jose , Lantvit Daniel D , Perez-Jiminez Francisco , Lopez-Miranda Jose , Swanson Steven M , Castano Justo P , Luque Raul M , Kineman Rhonda D

ESE Young Investigator AwardIntroduction: GH and IGF1 are thought to promote breast carcinogenesis as circulating levels of GH/IGF1 are positively correlated with breast cancer risk in epidemiologic studies, and mouse models with developmental GH/IGF1 deficiency or resistance are less susceptible to breast cancer development. However, no studies have shown that high levels of circulating GH/IGF1 can promote mammary tumorigenesis. In this...

ea0026s3.2 | Molecular mechanisms in neuroendocrine tumours | ECE2011

A new truncated variant of somatostatin receptor subtype five, sst5TMD4, is present in pituitary tumours and breast cancer, and impairs the normal response to somatostatin

Castano Justo P , Gahete Manuel D , Cordoba-Chacon Jose , Martinez-Fuentes Antonio J , Lopez-Sanchez Laura M , Gracia-Navarro Francisco , Luque Raul M

Somatostatin receptors (sst1–sst5) comprise a family of G-protein-coupled, 7 transmembrane domain (TMD) receptors encoded by five separate, intronless genes widely distributed throughout the organism. Somatostatin (SST) and cortistatin (CORT), two highly-related cyclic neuropeptides, bind to sst1–sst5 with comparable subnanomolar affinity to exert a number of (patho)physiological actions, from inhibition of endocrine secretions (e.g. GH and insulin), to the control o...

ea0022p443 | Endocrine tumours &amp; neoplasia (<emphasis role="italic">Generously supported by Novartis</emphasis>) | ECE2010

Is In2-ghrelin variant, a ghrelin gene derived transcript, a novel player in breast cancer tumors?

Gahete Manuel D , Cordoba-Chacon Jose , Hergueta Marta , Gracia-Navarro Francisco , Kineman Rhonda D , Moreno-Bueno Gema , Luque Raul M , Castano Justo P

Ghrelin has been classically known as a GH- and metabolism-regulating hormone, mainly produced by stomach. However, it also acts as a paracrine or autocrine factor in several tissues, where it can regulate tissue growth and neoplastic cell proliferation. Of note, ghrelin needs to be acylated at Ser3 by the ghrelin-O-acyltransferase (GOAT) enzyme to bind to its receptor GHS-R1a. Interestingly, the ghrelin gene can give rise to distinct additional peptides, generated by alternat...

ea0022p654 | Neuroendocrinology and Pituitary (<emphasis role="italic">Generously supported by Novartis</emphasis>) | ECE2010

Presence of kiss1/kiss1r system at the pituitary, testis and adipose tissue in rodents: functional actions and regulation by physiological cues

Gutierrez-Pascual Ester , Cordoba-Chacon Jose , Pinilla Leonor , Gracia-Navarro Francisco , Luque Raul M , Malagon Maria M , Tena-Sempere Manuel , Martinez-Fuentes Antonio J , Castano Justo P

It is now widely accepted that the kisspeptins (kps) and their receptor kiss1r play an essential role in the neuroendocrine regulation of the reproductive axis by stimulating hypothalamic GnRH secretion. However, kiss1 and kiss1r expression in tissues distinct from, but related to, the hypothalamus, prompted us to propose that these molecules may exert regulatory functions in additional places of the neuroendocrine system, such as the pituitary and two of its phy...

ea0020p187 | Endocrine tumours and neoplasia | ECE2009

Presence and potential pathophysiological relevance of GOAT, the ghrelin O-acylation enzyme, in human pituitary tumors

Quintero Ana , Martinez-Fuentes Antonio J , Dieguez Carlos , Benito-Lopez Pedro , Leal Alfonso , Webb Susan , Malagon Maria M , Luque Raul M , Castano Justo P

Ghrelin was isolated from stomach by its ability to stimulate growth hormone (GH) release through the GH-secretagogue receptor (GHS-R1a). However, ghrelin/GHS-R expression in multiple tissues and tumor types suggested additional roles for this tandem. Ghrelin, a 28-aminoacid peptide, requires a unique O-acylation at its Ser-3 residue to bind GHS-R1a and release GH. Conversely, unacylated ghrelin (UAG), initially considered inactive, seems to play distinct metabolic role...

ea0016p463 | Neuroendocrinology | ECE2008

Identification and molecular characterization of new somatostatin receptor subtype 5 truncated isoforms in rodents

Cordoba-Chacon Jose , Luque Raul M , Gahete Manuel D , Duran-Prado Mario , Gracia-Navarro Francisco , Kineman Rhonda D , Malagon Maria M , Castano Justo P

The neuropeptide somatostatin (SRIF) exerts a wide variety of actions through five SRIF receptors (sst1-5). However, not all SRIF actions can be explained by activation of the known sst. In this context, our research group has identified two novel isoforms of sst subtype 5 (sst5A) named sst5B and sst5C expressed in human and pig. These isoforms are generated by splicing of cryptic introns within the coding sequence, which alters the open reading frame, and results in new, trun...

ea0056oc4.1 | Novel insights into prediabetes and type 2 diabetes | ECE2018

Dietary intervention modulates the expression of the splicing machinery in patients at high-risk of type 2 diabetes development: clinical implications

del Rio-Moreno Mercedes , Alors-Perez Emilia , Camargo Antonio , Delgado-Lista Javier , Lopez-Canovas Juan L. , Lopez-Miranda Jose , Luque Raul M. , Gahete Manuel D. , Castano Justo P.

Development of type-2 diabetes (T2D) is critically affected by the loss of phenotypic flexibility. There is emerging evidence suggesting that, under adverse metabolic conditions, alternative mRNA splicing is markedly dysregulated at different levels. For this reason, we hypothesized that such dysregulation could contribute to loss of phenotypic flexibility. Consequently, we aimed to explore whether changes in the splicing machinery in peripheral blood mononuclear cells (PBMCs)...

ea0056gp157 | Obesity | ECE2018

Obesity is associated with a dysregulation in the splicing machinery components at the hepatic level: influence of metformin

L-Lopez Fernando , Alors-Perez Emilia , del Rio-Moreno Mercedes , Sarmento-Cabral Andre , Castano Justo P , Luque Raul M , Gahete Manuel D

Obesity, a multifactorial chronic endocrine-metabolic disease, represents one of the most serious and complex global health threats, as it is commonly associated with multiple and severe comorbidities (e.g. diabetes type-2). Indeed, as a source of severe metabolic-dysregulation, obesity alters physiological, homeostatic gene expression patters in multiple metabolic-tissues, including the central metabolic hub, i.e. the liver. However, the precise molecular mechanisms underlyin...

ea0056p652 | Endocrine tumours and neoplasia | ECE2018

Metformin and Simvastatin: a therapeutic combination to reduce the aggressiveness of glioblastoma multiforme

Fuentes-Fayos Antonio C , Vazquez-Borrego Mari C , Mansfield Beth , Blanco-Acevedo Cristobal , Solivera Juan , Castano Justo P , Luque Raul M

Gliomas constitute the most frequent type of brain tumors and are characterized by a rapid growth and high diffusion through the brain. In particular, astrocytomas are a subtype of malignant gliomas that are graded from low to high aggressiveness (i.e. grade I, II, III and IV), being grade IV (glioblastoma multiforme, GBM) the most malignant type, and one of the most common cancers in the brain and CNS. To date, surgery is the first-line therapy combined with chemotherapy or r...

ea0056p785 | Pituitary - Basic | ECE2018

Treatment with antidiabetic biguanide drugs directly impacts the function of multiple pituitary cell types from two non-human primate models

Leon-Gonzalez Antonio J , Vazquez-Borrego Mari C , Fuentes-Fayos Antonio C , Gahete Manuel D , Castano Justo P , Kineman Rhonda D , Luque Raul M

Antidiabetic biguanides, such as metformin (the most commonly prescribed drug to treat type 2 diabetes) and phenformin, are synthetic insulin-sensitizing agents. In addition to their well-known anti-hyperglycemic actions, biguanides are being also studied in other medical disorders due to the beneficial effects that they exert in important pathologies, including cardiovascular disease or different types of cancer. Although some scattered studies have suggested that metformin c...